Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is getting better, and use is not mandatory.

Insiders at the Food and Drug Administration are ringing alarm bells over the agency's use of an AI to fast-track drug approvals. As CNN reports, six current and former FDA officials are warning that the AI,

But three of those FDA employees told CNN that Elsa just makes up nonexistent studies, something commonly referred to in AI as “hallucinating.” The AI will also misrepresent research, according to these employees.

The Food and Drug Administration's new AI tool, Elsa, is reportedly generating false studies, raising concerns about the rapid approval of new drugs.